Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2009; 5(0): 147-153


THE PROTECTIVE EFFECT OF GINGER AGAINST THE NEPHROTOXICITY OF CISPLATIN IN MALE RATS

Mohamed F. Ismail, Ahmed M. Abdeen, Doaa A. Ali, Mai A. Mostafa.




Abstract

Ginger, the rhizome of Zingiber officinale, is a common condiment for various foods and beverages. Ginger has a long history of medicinal use dating back to 2500 years. One ml of an aqueous extract of ginger 120 mg/ml was orally given to male rats, every other day, to evaluate its nephroprotective effect against cisplatin-induced nephrotoxicity. Treatment with three consecutive injections of 10 mg/kg of cisplatin caused significant body weight loss, elevation in serum blood urea nitrogen (BUN), and creatinine levels. These changes were markedly attenuated in the rats protected with ginger before treatment with cisplatin. The applied dose of cisplatin caused marked histopathological renal alterations such as damage in Malpighian corpuscles, necrosis in the epithelia of the renal tubules, leucocytic infiltration, and increased the immunohistochemical expression of Bax proapoptotic protein. In the combined treatment, an improvement occurred in both histopathological observation and immunohistochemical investigation of Bax proapoptotic protein.

Key words: Ginger, cisplatin-nephrotoxicity, immunohistochemistry, BUN, creatinine






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.